Bladder cancer is relatively common in adults; however, in children, bladder malignancies are extremely rare. In the present case report, we describe the diagnostic, therapeutic, and follow-up management ... bladder…
Bladder cancer represents a significant global health concern, with a diverse range of risk factors influencing its occurrence. This systematic review provides a comprehensive update on the epidemiology of bladder…
Bladder cancer is a highly heterogeneous neoplasm. We examined the gene expression profile in 3 bladder cancer stages (Ta, T1, T2) using expression microarray analysis of 40 bladder tumors. Differentially ... COL1A1…
Background: The incidence of gall bladder cancers in this part of the world is high and the spatial variation in occurrence of gall bladder cancers can be identified by using ... geographical information system…
rs9642880 (G>T) at the 8q24.1 locus is thought to be associated with bladder cancer risk based on the results of genome-wide association studies, but the results remain inconclusive ... assess the association between…
Genetic alterations related to carcinogenesis, including punctual mutations, may have a potential as bladder cancer biomarker with high specificity and sensitivity. Specific acquired FGFR3 and HRAS mutations have been…
breakdown of the extracellular matrix, and thus eases metastasis and invasion. In patients with bladder cancer, intravesical chemo-immunotherapies are administered to reduce the risk of progression. In order ... examine…
This article delves into the transformative landscape of bladder cancer surgery, exploring advancements that are reshaping the way we approach treatment. From traditional open surgeries to cutting-edge minimally…
Bladder cancer is a formidable adversary, affecting millions of people worldwide and causing substantial morbidity and mortality. However, the field of bladder cancer research has made remarkable progress in recent…
Bladder cancer poses a significant clinical challenge due to its diverse molecular landscape and variable clinical outcomes. Genetic markers and molecular diagnostics have emerged as indispensable tools in the diagnosis…
unused cancer treatment procedure that has appeared promising potential for bladder cancer treatment. The position of the bladder cancer at diverse areas along the bladder divider lining can possibly influence…
Introduction: According to the European Urologic Guidelines up to 85% of urothelial cancer of the bladder (UCa) is diagnosed at the non-metastatic stage, being gross haematuria the most common
Bladder cancer remains one of the most prevalent cancers and is considered to be one of the primary causes of morbidity and mortality worldwide. Nonetheless, the treatment and management ... malignancy can be very…
including a central boost to ordinary fractionated EBRT within the treatment of localized prostate cancer, the five-year biochemical disease-free survival expanded, without altogether expanding poisonous quality. The…
protein kinase expression and investigates its possible association with the clinicopathological factors of urinary bladder cancer to estimate its clinical usefulness in diagnosis and prognosis. This retrospective study…
date, no study has investigated the association between CYP1A2-163C/A polymorphism and bladder cancer risk in a Chinese population. Here, we extracted genomic DNA from peripheral white blood cells ... revealed that the…
This study evaluated the efficacy of hexaminolevulinate fluorescence cystoscopy as a diagnostic tool for bladder cancer. The study was a case series in the Department of Urology in Hippokratio General ... clinical…
Introduction: In Algeria, the bladder cancer is the second urologic cancer after the prostate. Several risk factors are implicated in particular tobacco. The aim of this study is to evaluate ... university hospital of…
lack of personalized management of bladder cancer (BlCa) resulted in patients’ lifelong post-treatment monitoring with regular invasive interventions, underlying the urgent need for tailored and minimally invasive…
bladder tumour (TURBT) for patients with T1 grade 3 (G3) and T2--3N0M0 bladder cancers. Material and methods: Patients were 27 males and 7 females with a median
association between the prostate stem cell antigen (PSCA) rs2294008 (C>T) polymorphism and bladder cancer risk, but the results remain inconclusive. In order to derive a more precise estimation ... meta-analysis showed…
safety of compound aluminum sulfate injection (CASI) in the treatment of non-muscle invasive bladder cancer(NMIBC) in patients. Methods: A multi-center, open and non-controlled phase ... treatment of NMIBC. Key Words…
accompany variation in molecules structure, where the concentration of lipid is lower in cancerous urinary bladder tissues, unlike normal tissue, while the content of protein and collagen have been increased ... bladder…
therapy currently available, most of the patients relapse. MicroRNA- 100 is down regulated in bladder cancer tissue in comparison to normal tissue; however, clinical significance of miR-100 in human ... bladder cancer…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.